Peter serves as Chief Executive Officer for Medlumics bringing over 40 years of extensive engineering and operational experience in medical device design, development, and commercialization.

Peter Hinchliffe is a highly accomplished and experienced leader in the medical device industry, having successfully built and led multi-disciplinary teams at companies including; Jarvik Heart, Getinge, DataScope, Rex Medical, United States Surgical Corporation, now Medtronic, in various functions, including product development, manufacturing, quality assurance, regulatory approval, marketing, and direct and distributor sales. With a strong engineering background, Peter has been involved in the advancement of multi-billion dollar, multi-million dollar, and start-up companies, with his expertise spanning across a range of medical specialty devices. He holds over 110 issued US medical device patents and has more than 100 still pending.

Christophe holds multiple academic degrees including, an engineering degree from the Université de Technologie de Compiègne in France, an MSc in blood transfusion and immunology, a PhD in immuno-biotechnologies and an MBA from ESSEC in Paris, France. He is has been co-author in numerous scientific publications and patent.

Christophe started his career in a French biotech startup affiliate of the National Blood Transfusion Foundation in the late 80s. Then He spent 5 years in Germany as a research and quality assurance manager in a young CRO, PRA International. He then spent 5 years in the clinical development field for Cardiac Rhythm Management at Ela Medical, which was part of Sorin Group. From 2002 to 2014 he was based in Belgium as the VP of Clinical Affairs and Health Economics of the International Division at St. Jude Medical covering all product lines CRM, Atrial Fibrillation, Cardiac Surgery, Interventional Cardiology and Neuromodulation.

Then He joined the Executive Committee of Mauna Kea Technologies, world leader in endomicroscopy, as VP Clinical and Regulatory Affairs, Health Economics and Market Access and Corporate Compliance Officer based in Paris, France.

Lucía accumulates more than 10 years’ experience in banking, international controllership and financial management of high-growth technology start-ups. Previous positions of Financial Manager for Small and Medium Enterprises in “la Caixa” and Financial leader in Integromics’ group. She also holds significant experience within Public funding, National and European programs, FP7, H2020, and she is expert for H2020 since 2019.

Lucía Colmenero holds a degree in Business Administration, with a major in Finance, a MBA and a Master in Finance and accumulates a wide experience in spin-off creation and growth from her position as Technical Project Manager in the Company Start-up Support Unit of the Spanish National Research Council (CSIC), and also from her academic experience in the study of key economical factors for the creation of spin-off companies.

She contributes to fund-raising activities resulting in a 34,4M€ in private investments in 2017 .